| Dr David R Zimmermann, PHD | |
|
616 W Russell Pl, San Antonio, TX 78212-3658 | |
| (800) 257-8715 | |
| (800) 819-1655 |
| Full Name | Dr David R Zimmermann |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 39 Years |
| Location | 616 W Russell Pl, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003854894 | NPI | - | NPPES |
| 620003797 | Other | TX | RAILROAD |
| 115667101 | Medicaid | TX | |
| 86122A | Other | TX | BLUE CROSS BLUE SHIELD |
| 115667102 | Medicaid | TX | |
| 86044A | Other | TX | BLUE CROSS BLUE SHIELD |
| 86147A | Other | TX | BLUE CROSS BLUE SHIELD |
| 86383A | Other | TX | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 23396 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Deer Oaks Geriatric Services P C | 9234034075 | 45 |
News Archive
A type of cell plentiful in the brain, long considered mainly the stuff that holds the brain together and oft-overlooked by scientists more interested in flashier cells known as neurons, wields more power in the brain than has been realized, according to new research published today in Science Signaling.
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
CRISPR/Cas9 is hot. News of the revolutionary gene editing technique that is already shaking up bioscience has finally reached the news media and the public. Now comes a first rate example of how CRISPR is changing the pace of biomedical research by linking up with another cutting edge technology - human pluripotent stem cells (hPSCs).
QLT Inc. today announced that its wholly-owned U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"), and Quantel Medical and its distributor, Quantel USA, Inc., have entered into a co-promotion agreement for the sale of Activis PDT Lasers used to activate Visudyne® during photodynamic therapy of primarily classic lesions in wet age-related macular degeneration (AMD). The lasers are manufactured by Quantel Medical and sold by Quantel USA, Inc. and will be promoted by both Quantel USA, Inc. and QOI's sales force to the retina community in the United States.
The laboratory of Dr. Fr-d-ric Charron, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered a new molecular mechanism that permits the guidance of visual nerves towards the brain.
› Verified 6 days ago
| Entity Name | Deer Oaks Geriatric Services P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134169287 PECOS PAC ID: 9234034075 Enrollment ID: O20031204000440 |
News Archive
A type of cell plentiful in the brain, long considered mainly the stuff that holds the brain together and oft-overlooked by scientists more interested in flashier cells known as neurons, wields more power in the brain than has been realized, according to new research published today in Science Signaling.
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
CRISPR/Cas9 is hot. News of the revolutionary gene editing technique that is already shaking up bioscience has finally reached the news media and the public. Now comes a first rate example of how CRISPR is changing the pace of biomedical research by linking up with another cutting edge technology - human pluripotent stem cells (hPSCs).
QLT Inc. today announced that its wholly-owned U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"), and Quantel Medical and its distributor, Quantel USA, Inc., have entered into a co-promotion agreement for the sale of Activis PDT Lasers used to activate Visudyne® during photodynamic therapy of primarily classic lesions in wet age-related macular degeneration (AMD). The lasers are manufactured by Quantel Medical and sold by Quantel USA, Inc. and will be promoted by both Quantel USA, Inc. and QOI's sales force to the retina community in the United States.
The laboratory of Dr. Fr-d-ric Charron, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered a new molecular mechanism that permits the guidance of visual nerves towards the brain.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David R Zimmermann, PHD 6915 Robert Dixon Dr, Austin, TX 78749-2268 Ph: (512) 892-2196 | Dr David R Zimmermann, PHD 616 W Russell Pl, San Antonio, TX 78212-3658 Ph: (800) 257-8715 |
News Archive
A type of cell plentiful in the brain, long considered mainly the stuff that holds the brain together and oft-overlooked by scientists more interested in flashier cells known as neurons, wields more power in the brain than has been realized, according to new research published today in Science Signaling.
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
CRISPR/Cas9 is hot. News of the revolutionary gene editing technique that is already shaking up bioscience has finally reached the news media and the public. Now comes a first rate example of how CRISPR is changing the pace of biomedical research by linking up with another cutting edge technology - human pluripotent stem cells (hPSCs).
QLT Inc. today announced that its wholly-owned U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"), and Quantel Medical and its distributor, Quantel USA, Inc., have entered into a co-promotion agreement for the sale of Activis PDT Lasers used to activate Visudyne® during photodynamic therapy of primarily classic lesions in wet age-related macular degeneration (AMD). The lasers are manufactured by Quantel Medical and sold by Quantel USA, Inc. and will be promoted by both Quantel USA, Inc. and QOI's sales force to the retina community in the United States.
The laboratory of Dr. Fr-d-ric Charron, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered a new molecular mechanism that permits the guidance of visual nerves towards the brain.
› Verified 6 days ago
Joshua D Essery, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8535 Tom Slick, San Antonio, TX 78229 Phone: 210-616-0300 | |
Dr. Jesus Aranda-cano, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 7400 Blanco Rd, Suite 126, San Antonio, TX 78216 Phone: 210-699-8700 | |
Dr. Nancy Sylvia L. Witt, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 7272 Wurzbach Rd, Suite 706, San Antonio, TX 78240 Phone: 210-615-3483 Fax: 210-593-9863 | |
Russel L Thompson, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 7400 Blanco Road, Suite 126, San Antonio, TX 78216 Phone: 210-699-8700 Fax: 210-587-2454 | |
Jennifer Cleveland, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 614 Walnut Hill St, San Antonio, TX 78232 Phone: 917-774-1335 | |
Michael J. Mcmains, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1207 Brooklyn Ave, San Antonio, TX 78212 Phone: 210-472-2090 Fax: 210-472-2062 |